Ms. Mina Suh, along with colleagues within EpidStrategies (a Division of ToxStrategies), and external collaborators, has been conducting research on respiratory syncytial virus (RSV), especially as it relates to infants and children in the United States. In a prospective viral surveillance study, which was recently accepted… read more
The team of epidemiologists at EpidStrategies (a Division of ToxStrategies), along with colleagues in industry and academia, have been deeply involved in ongoing research on respiratory syncytial virus (RSV) in… read more
EpidStrategies, a division of ToxStrategies is excited to be participating in the American Society of Hematology Annual Meeting, which will be held virtually on December… read more
Dr. Naushin Hooda, an EpidStrategies Doctor of Pharmacy based in Toronto, will participate in a virtual panel discussion as part of the Canadian… read more
EpidStrategies scientists, including Dr. Jon Fryzek, Ms. Mina Suh, Ms. Heidi Reichert, Ms. Lauren Bylsma, Dr. Sarah Cohen, Ms. Xiaohui Jiang, and Ms…. read more
EpidStrategies scientists have collaborated with toxicologists from ToxStrategies’ Biopharmaceuticals/Pharmaceuticals Practice to produce a white paper that provides “Critical insights into nonclinical toxicology and… read more
The European Society for Medical Oncology (ESMO) Academy has gone virtual for 2020, and Ms. Naimisha Movva and Dr. Jon Fryzek will present… read more
EpidStrategies, a division of ToxStrategies, Inc., has opened a position for an epidemiologist to join our team of epidemiologists and statisticians conducting systematic… read more
EpidStrategies epidemiologists Dr. Jon Fryzek and Ms. Lauren Bylsma will present a poster at the “Rare Diseases and Orphan Products Breakthrough Summit,” to… read more
Scientists from EpidStrategies, a Division of ToxStrategies, presented at the 35th International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ICPE). The August 2019… read more